Cargando…

A Novel Association of Neuropilin-1 and MUC1 in Pancreatic Ductal Adenocarcinoma: Role in Induction of VEGF Signaling and Angiogenesis

We report that MUC1, a transmembrane glycoprotein that is overexpressed in >80% of pancreatic ductal adenocarcinoma (PDA) induced a pro-angiogenic tumor microenvironment by increasing the levels of neuropilin-1 (NRP1, a co-receptor of VEGF) and its ligand, VEGF. Expression of tumor-associated MUC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ru, Curry, Jennifer M, Roy, Lopamudra Das, Grover, Priyanka, Haider, Jamil, Moore, Laura J., Wu, Shu-ta, Kamesh, Anishaa, Yazdanifar, Mahboubeh, Ahrens, William A., Leung, TinChung, Mukherjee, Pinku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960005/ https://www.ncbi.nlm.nih.gov/pubmed/26804176 http://dx.doi.org/10.1038/onc.2015.516

Ejemplares similares

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
por: Bose, Mukulika, et al.
Publicado: (2022)

Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2019)

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
por: Zhou, Ru, et al.
Publicado: (2019)

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
por: Zhou, Ru, et al.
Publicado: (2020)

Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice
por: Curry, Jennifer M., et al.
Publicado: (2019)

MUC1 Regulates PDGFA Expression During Pancreatic Cancer Progression
por: Sahraei, Mahnaz, et al.
Publicado: (2012)

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors()()
por: Moore, Laura Jeffords, et al.
Publicado: (2016)

Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer
por: Nath, Sritama, et al.
Publicado: (2015)

SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line
por: Grover, Priyanka, et al.
Publicado: (2018)

Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population
por: Kidiyoor, Amritha, et al.
Publicado: (2014)

Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers
por: Bose, Mukulika, et al.
Publicado: (2020)

Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models
por: Sahraei, Mahnaz, et al.
Publicado: (2021)

Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles
por: Wu, Shu-ta, et al.
Publicado: (2018)

Rescue of hematopoietic stem/progenitor cells formation in plcg1 zebrafish mutant
por: Ferri-Lagneau, Karine F., et al.
Publicado: (2019)

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
por: Roy, Lopamudra Das, et al.
Publicado: (2010)

Angiogenesis versus arteriogenesis: neuropilin 1 modulation of VEGF signaling
por: Kofler, Natalie M., et al.
Publicado: (2015)

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
por: Hansen, Wiebke
Publicado: (2013)

The Neuropilin 1 Cytoplasmic Domain Is Required for VEGF-A-Dependent Arteriogenesis
por: Lanahan, Anthony, et al.
Publicado: (2013)

A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells
por: Barr, M P, et al.
Publicado: (2005)

VEGF/Neuropilin Signaling in Cancer Stem Cells
por: Mercurio, Arthur M.
Publicado: (2019)

Targeting Neuropilin-1 to Inhibit VEGF Signaling in Cancer: Comparison of Therapeutic Approaches
por: Gabhann, Feilim Mac, et al.
Publicado: (2006)

Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma
por: Dréau, Didier, et al.
Publicado: (2019)

Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
por: Do, Sung-Im, et al.
Publicado: (2013)

VEGF Signaling through Neuropilin 1 Guides Commissural Axon Crossing at the Optic Chiasm
por: Erskine, Lynda, et al.
Publicado: (2011)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

Discriminating Different Cancer Cells Using a Zebrafish in Vivo Assay
por: Moshal, Karni S., et al.
Publicado: (2011)

Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma
por: Matkar, Pratiek N., et al.
Publicado: (2016)

Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1–dependent ABL1 activation in endothelial cells
por: Raimondi, Claudio, et al.
Publicado: (2014)

VEGF-A121a binding to Neuropilins – A concept revisited
por: Sarabipour, Sarvenaz, et al.
Publicado: (2017)

Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021)

Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes
por: Pathangey, Latha B., et al.
Publicado: (2016)

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects
por: Borchardt, Hannes, et al.
Publicado: (2019)

Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction
por: Jarvis, Ashley, et al.
Publicado: (2010)

Mechanism of Selective VEGF-A Binding by Neuropilin-1 Reveals a Basis for Specific Ligand Inhibition
por: Parker, Matthew W., et al.
Publicado: (2012)

Crystal Structure of the Neuropilin-1 MAM Domain: Completing the Neuropilin-1 Ectodomain Picture
por: Yelland, Tamas, et al.
Publicado: (2016)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice
por: Lakshminarayanan, Vani, et al.
Publicado: (2016)

Neuropilin-1 in Transplantation Tolerance
por: Campos-Mora, Mauricio, et al.
Publicado: (2013)

Preclinical evaluation of an (111)In/(225)Ac theranostic targeting transformed MUC1 for triple negative breast cancer
por: Kelly, Vanessa J, et al.
Publicado: (2020)

Distinct Roles for Neuropilin1 and Neuropilin2 during Mouse Corneal Innervation
por: McKenna, Chelsey C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_puve5b2blrqlc36mv8ae9oi0mk